Thu, 01/16/2025 - 20:53 |
Meet the 2025 YWCA Women of Distinction nominees in our community |
McMasterUniv |
Thu, 01/17/2019 - 05:30 |
Professor Jane Norman appointed as the new Dean for the Faculty of Health Sciences |
University of B... |
Mon, 12/10/2018 - 21:58 |
New plan to cut harm from too much medicines in older people |
SydneyUniv |
Tue, 12/04/2018 - 06:17 |
Winners of the prizes for the Best Doctoral Research Theses 2017/18 |
University of B... |
Wed, 10/03/2018 - 17:11 |
Sydney women talk gender equity |
SydneyUniv |
Wed, 09/19/2018 - 23:20 |
Introducing the New ISTH SSC Subcommittee Chairs |
ISTH |
Tue, 09/11/2018 - 14:45 |
ANCC Board of Directors Appoints Individuals to Three ANCC Commissions |
American Nurses... |
Wed, 08/29/2018 - 23:19 |
Positive phase III results for Roches Hemlibra for haemophilia A without factor VIII inhibitors published in New England Journal of Medicine |
Rocheusa |
Wed, 08/29/2018 - 11:38 |
Positive Phase III Results for Genentechs HEMLIBRA (emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors Published in New England Journal of Medicine |
Genentech |
Wed, 08/01/2018 - 11:13 |
Bristol launches the new Faculty of Life Sciences |
University of B... |
Mon, 06/25/2018 - 01:37 |
New research reveals how rugby league players make it to the top |
SydneyUniv |
Tue, 05/22/2018 - 16:23 |
, the professional society for health economics and outcomes research, recognized honorees of the ISPOR Awards Program at its |
ISPOR |
Tue, 05/22/2018 - 14:45 |
ISPOR Presents 2018 Awards for Outstanding Achievement in Health Economics and Outcomes Research |
ISPOR |
Sun, 05/20/2018 - 22:43 |
Roches Hemlibra reduced treated bleeds by 96 percent compared to no prophylaxis in phase III HAVEN 3 study in haemophilia A without factor VIII inhibitors |
Rocheusa |
Thu, 05/17/2018 - 06:35 |
New England Journal of Medicine publishes two trials for Symbicort as an anti-inflammatory reliever therapy as needed in mild asthma |
AstraZeneca |
Mon, 05/14/2018 - 00:05 |
University of Sydney to continue partnership with TEDx in 2018 |
SydneyUniv |
Thu, 04/12/2018 - 22:30 |
University of Sydney at forefront of digital health research |
SydneyUniv |
Mon, 04/09/2018 - 06:48 |
ISPOR Announces Honorees for 2018 Awards Program |
ISPOR |
Mon, 03/19/2018 - 14:32 |
Gum disease having devastating impact on general health and well-being warn dentists |
University of B... |
Wed, 01/31/2018 - 23:52 |
Kids born later in the year can still excel in sport |
SydneyUniv |
Mon, 01/29/2018 - 18:41 |
Report identifies NDIS gaps for people living with mental illness |
SydneyUniv |
Thu, 01/25/2018 - 11:44 |
Emerging research pioneers championed with fellowships |
SydneyUniv |
Tue, 01/23/2018 - 19:27 |
Backpacks, shoes, and bedtimes: our experts' back to school tips |
SydneyUniv |
Sun, 11/19/2017 - 23:51 |
Roches Hemlibra significantly reduced bleeds in phase III study in haemophilia A |
Rocheusa |
Sat, 11/18/2017 - 22:58 |
Genentechs Hemlibra (Emicizumab-kxwh) Significantly Reduced Bleeds in Phase III Study in Hemophilia A |
Genentech |